 Induction chemotherapy new regimen cisplatin fluorouracil mitomycin hydroxyurea bleomycin carcinomas nasopharynx sites head neck region Sixty-six patients Stages III IV carcinoma head neck cycles induction chemotherapy cisplatin fluorouracil FU infusion bleomycin mitomycin hydroxyurea radiotherapy and/or surgery men women median age years range years Karnofsky performance status range Primary site nasopharynx patients larynx others patients Stage IV disease response rate induction chemotherapy complete response partial response stable disease progressive disease significant difference response rate patients cancer nasopharynx sites Survival months Patients cancer nasopharynx survival primaries Toxicities chemotherapy alopecia leukopenia stomatitis anemia diarrhea Grade IV toxicity Induction chemotherapy new regimen high response rate superior FU radiotherapy curative therapy squamous cell carcinoma head neck Chemotherapy radiation therapy survival similar radical surgery laryngeal head neck cancers